On February 3, 2026, Sisvel took a significant step forward in advancing transparency through its collaboration with the ...
Kymera Therapeutics (KYMR) stays a Strong Buy on KT-621 Phase 1b AD results, FDA Fast Track, and $1.6B cash runway—click to ...
The inquiry confirmed that Khalid was on the No Fly List, a subset of the broader Terrorist Screening Dataset, commonly known ...
Live animal markets and the illegal sale of wildlife pose particular dangers, but any sale of wild animals or animal products ...
Microsoft recently released a new preview build of Windows 11 for the Windows Insider channels. Users enrolled in the Insider ...
Adcendo secures $75M Series C funding to advance innovative cancer therapies and expand its antibody-drug conjugate pipeline.
Drugs were left out of a 2024 rule streamlining prior authorizations by making decisions electronic and requiring payers to ...
AI advances and rising geopolitical tensions are helping usher in a new phase of investment in space infrastructure, according to quarterly research released April 14 by early-stage investor Space ...
H.R. 1, the reconciliation bill passed in July 2025, enacted a provision that takes away Medicaid from certain adults who can ...
Howard Marks examines the evolution of private credit and the risks posed by the current boom in direct lending and software ...
Repilot synthesizes a candidate patch through the interaction between an LLM and a completion engine, which prunes away ...
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results